SEQ Limited
http://www.seq.co.im/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From SEQ Limited
Pfizerizing Bristol
Under the influence of Leon Rosenberg, Bristol-Myers Squibb's research department was one of the industry most active early-stage deal makers. Now, Bristol has a new head of research, former Pfizer head of discovery research, Peter Ringrose, who is already talking about reducing the number of early-stage and platform deals to focus instead on deals that will produce INDs within two years of signing the collaboration.
The New Deal Structures: The Recipe is Creativity
With capital markets depressed and internal R&D growing ever more expensive, biotech and Big Pharma need each other more than ever. But a new wave of skeptical drug partners are forcing humbled biotechs to write deals that minimize risk without driving down the deal's value.
Company Information
- Industry
- Pharmaceuticals
- Services
-
Services
- Consulting Services
- Group Purchasing
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice